(Q37925022)

25 August 2017

1 reference

title

Matricellular proteins: new molecular targets to prevent heart failure (English)

1 reference

25 August 2017

0 references

Hiroshi Okamoto

1

1 reference

25 August 2017

Kyoko Imanaka-Yoshida

series ordinal

2

1 reference

25 August 2017

publication date

4 August 2011

1 reference

Cardiovascular Therapeutics

25 August 2017

published in

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

e198-209

1 reference

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Matricellular proteins: extracellular modulators of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Matricellular proteins in the heart: possible role during stress and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Thrombospondins in the heart: potential functions in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The interaction of Thrombospondins with extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Thrombospondins function as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The role of thrombospondins in wound healing, ischemia, and the foreign body reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The role of SPARC in extracellular matrix assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Functions and mechanisms of action of CCN matricellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

SPARC functions as an inhibitor of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Origin of cardiac fibroblasts and the role of periostin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Myocardial osteopontin expression coincides with the development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Osteopontin expression is required for myofibroblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

A constitutive endogenous osteopontin production is important for macrophage function and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Myocardial osteopontin expression is associated with left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Osteopontin and cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Role of osteopontin in heart failure associated with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The regulation of tenascin expression by tissue microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascins: regulation and putative functions during pathological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C induced signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Mice develop normally without tenascin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Skin wounds and severed nerves heal normally in mice lacking tenascin-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Noninvasive detection of cardiac repair after acute myocardial infarction in rats by 111 In Fab fragment of monoclonal antibody specific for tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C is a useful marker for disease activity in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Active interstitial remodeling: an important process in the hibernating human myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: assessment by 125I-anti-tenascin-C antibody imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The myofibroblast in wound healing and fibrocontractive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Tenascin-C-coated platinum coils for acceleration of organization of cavities and reduction of lumen size in a rat aneurysm model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

CCN proteins: multifunctional signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

CCN family proteins and angiogenesis: from embryo to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

CYR61 (CCN1) is essential for placental development and vascular integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

The role of the thrombospondins in healing myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Expression of fasciclin I and II glycoproteins on subsets of axon pathways during neuronal development in the grasshopper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Periostin as a heterofunctional regulator of cardiac development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Periostin is essential for cardiac healing after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00276.X

10.1111/J.1755-5922.2011.00276.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference